ABEO Abeona Therapeutics Dashboard

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

Company profile

Ticker

ABEO

Exchange

NASDAQ

Website

abeonatherapeutics.com/

CEO

Jeffrey Davis

Incorporated

Delaware

Location

New York

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Merck & Co • Allergan • Johnson & Johnson • Abbott Laboratories • Teva- Pharmaceutical Industries • Viatris • Bristol-Myers Squibb • Lilly(Eli) & Co • Warner Chilcott ...

Former names

ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC, PLASMATECH BIOPHARMACEUTICALS INC

SEC CIK

0000318306

Corporate docs

Articles of Incorporation & Bylaws

IRS number

830221517

ABEO stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

Abeona Therapeutics Q4 EPS $(0.17) Up From $(0.30) YoY, Sales $3.00M

24 Mar 21

Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.17) per share. This is a 43.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported $3.00 million in

33 Stocks Moving in Friday's Pre-Market Session

26 Feb 21

Gainers Northern Dynasty Minerals Ltd. (NYSE: NAK) rose 85.7% to $1.30 in pre-market trading after the company said the US Army Corps of Engineers has accepted Pebble Limited Partnership's request to initiate an administrative appeal process.

10 Stocks Going Crazy Today On No News, Thursday, Feb. 25, 2021 (Via Benzinga Pro's Movers Tool)

25 Feb 21

GameStop (GME) Koss (KOSS) Abeona Therapeutics (ABEO) Puhui Wealth Investment (PHCF) TDH Holdings (PETZ) China Liberal Education (CLEU) Tian Ruixiang Holdings (TIRX) PubMatic (PUBM) Akouos (AKUS) Luminex

12 Health Care Stocks Moving In Thursday's Intraday Session

25 Feb 21

12 Health Care Stocks Moving In Friday's After-Market Session

19 Feb 21

Press releases

Pro users get this 30m faster

Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors

25 Mar 21

NEW YORK and CLEVELAND, March 25, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of two new independent members to

Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress

24 Mar 21

Fourth patient treated in pivotal Phase 3 VIITAL™ study of EB-101 in RDEB after successful Type B meeting with FDA Positive new interim data from MPS IIIA and MPS IIIB programs presented at 17th Annual

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Abeona Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

23 Mar 21

NEW YORK, March 23, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving

Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer

22 Mar 21

Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

22 Feb 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

24 Mar 21

18 Apr 21

31 Dec 21

Financial summary

Financial statements Chart ABEO financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	13.57M	13.57M	13.57M	13.57M	13.57M	13.57M
Cash burn (monthly)	(positive/no burn)	9.73M	4.83M	6.79M	536.67K	2.92M
Cash used (since last report)	n/a	35.22M	17.47M	24.55M	1.94M	10.56M
Cash remaining	n/a	-21.65M	-3.9M	-10.98M	11.63M	3.01M
Runway (months of cash)	n/a	-2.2	-0.8	-1.6	21.7	1.0

Beta Read what these cash burn values mean

Recent insider trades

ABEO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Apr 21	Carr Edward	Common stock	Sell	Dispose S	No	Yes	1.7956	35,000	62.85K	191,291
1 Apr 21	Carr Edward	Common stock	Sell	Dispose S	No	Yes	1.8521	20,445	37.87K	226,291
31 Mar 21	Michael Amoroso	Common stock	Sell	Dispose S	No	Yes	1.8701	45,409	84.92K	650,046
19 Mar 21	Michael Amoroso	Common stock	Grant	Aquire A	No	No	0	250,000	0	695,455
19 Mar 21	Michael Amoroso	Stock Option Common Stock	Grant	Aquire A	No	No	2.18	500,000	1.09M	500,000

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

ABEO institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders	Current	Prev Q	Change
Total holders	0	0
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	0	0
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Soligenix • Jazz Pharmaceuticals • Alder Biopharmaceuticals • Synedgen • Galera Therapeutics • uniQure • Regenxbio • Voyager Therapeutics • Editas Medicine • CRISPR Therapeutics

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AAA, absent, accommodate, adulterated, Aid, Alto, ambit, Amoroso, ANTIDILUTIVE, apparent, attest, bill, bioreactor, black, box, boxed, branch, bronchial, brought, Bruckner, capita, cDNA, chance, clarity, communicable, Condensed, congregating, controversy, corneal, counterfeit, credible, CRL, custody, danger, deadline, Dear, declaratory, Dermatology, detention, diarrhea, die, disagree, disbursed, disfiguring, disregard, donor, DQSA, draft, drop, EC, economy, embedded, embezzling, episode, ester, faith, fault, filer, filtered, fluorescent, forgiven, fovea, fused, fusing, gather, gave, GDP, George, Germany, gradually, green, grown, harvested, helper, heterogeneity, HHS, Hirsch, home, Hull, impractical, improperly, inaccurate, inactive, inconclusive, ineligible, inevitable, ingredient, Inline, intentionally, Interactive, interface, intermittent, intervene, Journal, justly, lattice, laying, lender, likewise, linear, loan, lowest, Mann, master, mechanistically, media, Michael, Migausky, MMA, moderate, mortgage, mutual, nasal, navigating, necessitate, neurodevelopmental, nil, noncompliance, notwithstanding, novo, nurse, obstructing, OECD, offense, openly, ophthalmic, Orphanet, outer, outweigh, owe, Page, Palo, pandemic, passed, pause, paused, Paycheck, PBM, PDMA, penetrated, pharmacy, photoreceptor, pigmented, plasmid, plausible, PMA, Poor, postpone, postponed, PPP, predicated, preempted, premarket, prioritize, prolonged, prudent, qualification, quantity, quarantine, qui, reassessing, redirected, redundancy, regain, reinstituting, Relief, remote, renegotiate, repay, repricing, resumed, resuming, reveal, revoked, route, running, salt, SBA, searchable, SGSH, shareholder, Shawn, shortage, shorter, sixty, starter, stealing, sum, surface, survey, tam, Taysha, temporarily, thought, timepoint, Tomasello, tracing, training, transient, trick, triple, true, truth, turnover, unanimously, unapproved, unexercised, unfit, unforeseen, unforgiven, untrue, unvested, variant, verify, veterinary, VIITALTM, virtual, vomiting, White, workforce

Removed: administering, Alvino, AMAG, amortizing, behavior, budget, buildup, burn, called, Chairman, collateral, collectible, commitment, correct, cumulative, detect, devoted, digest, Donald, doubtful, EBMRF, EBRP, eventual, fatty, Finland, graph, historic, HS, index, inflation, intrathecal, July, Junior, Leland, lesser, lysosome, MACM, Mark, match, mid, Miller, month, MPSIIIA, MuGard, NCL, NDA, Newfoundland, Norgine, northern, Obama, onset, originally, placement, poorly, President, prohibited, realizable, recalculated, recapitulate, recycle, Reorganization, Southern, speech, suggesting, Sweden, symptomatic, tagged, tenant, text, Timothy, Trump, unamortized, unqualified, view, week

From filing 10-K 2020 FY